Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Zhangjiang Hi-Tech Park Buys Stake in Buchang Pharma

publication date: Sep 28, 2009
Zhangjiang Hi-Tech Park Development Co. of Shanghai will invest another 48 million RMB ($7 million) in its venture capital subsidiary, Haocheng Venture Capital Co. so that Haocheng can purchase a .4% stake in Shandong Buchang Pharmaceutical Co. Zhangjiang will purchase the shares from Shenzhen China Euro Capital Co. They carry a provision requiring Shenzhen China Euro to take back the shares if Buchang Pharma does not list its shares by the end of 2013. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here